Novavax and Takeda Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate in Japan

Novavax will license COVID-19 vaccine technology to Takeda for local production and commercialization in Japan Matrix-M adjuvant to be supplied from Novavax Government of Japan will provide funding to Takeda for technology transfer, establishment of infrastructure and scale-up of manufacturing Adds to Takeda’s ongoing support of influenza pandemic preparedness in Japan GAITHERSBURG, Md. and OSAKA, […]

Read More